AAAAAA

   
Results: 1-20 |
Results: 20
Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke
Authors: Abdelkarim, GE Gertz, K Harms, C Katchanov, J Dirnagl, U Szabo, C Endres, M
Citation: Ge. Abdelkarim et al., Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke, INT J MOL M, 7(3), 2001, pp. 255-260
Effects of cerebral ischemia in mice lacking DNA methyltransferase I in post-mitotic neurons
Authors: Endres, M Fan, GP Meisel, A Dirnagl, U Jaenisch, R
Citation: M. Endres et al., Effects of cerebral ischemia in mice lacking DNA methyltransferase I in post-mitotic neurons, NEUROREPORT, 12(17), 2001, pp. 3763-3766
Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death
Authors: Katchanov, J Harms, C Gertz, K Hauck, L Waeber, C Hirt, L Priller, J von Harsdorf, R Bruck, W Hojrtnagl, H Dirnagl, U Bhide, PG Endres, M
Citation: J. Katchanov et al., Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death, J NEUROSC, 21(14), 2001, pp. 5045-5053
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
Authors: Strizki, JM Xu, S Wagner, NE Wojcik, L Liu, J Hou, Y Endres, M Palani, A Shapiro, S Clader, JW Greenlee, WJ Tagat, JR McCombie, S Cox, K Fawzi, AB Chou, CC Pugliese-Sivo, C Davies, L Moreno, ME Ho, DD Trkola, A Stoddart, CA Moore, JP Reyes, GR Baroudy, BM
Citation: Jm. Strizki et al., SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo, P NAS US, 98(22), 2001, pp. 12718-12723
Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyll-1 '-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4 '-methyl-1,4 '-bipiperidine N-oxide (SCH 351125):An orally bioavailable human CCR5 antagonist for the treatment of HIV infection
Authors: Palani, A Shapiro, S Clader, JW Greenlee, WJ Cox, K Strizki, J Endres, M Baroudy, BM
Citation: A. Palani et al., Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyll-1 '-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4 '-methyl-1,4 '-bipiperidine N-oxide (SCH 351125):An orally bioavailable human CCR5 antagonist for the treatment of HIV infection, J MED CHEM, 44(21), 2001, pp. 3339-3342
Biocompatible hydrogel supports the growth of respiratory epithelial cells: Possibilities in tracheal tissue engineering
Authors: Risbud, M Endres, M Ringe, J Bhonde, R Sittinger, M
Citation: M. Risbud et al., Biocompatible hydrogel supports the growth of respiratory epithelial cells: Possibilities in tracheal tissue engineering, J BIOMED MR, 56(1), 2001, pp. 120-127
Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment
Authors: Yamada, M Huang, ZH Dalkara, T Endres, M Laufs, U Waeber, C Huang, PL Liao, JK Moskowitz, MA
Citation: M. Yamada et al., Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment, J CEREBR B, 20(4), 2000, pp. 709-717
Ischemic brain damage in mice after selectively modifying BDNF or NT4 geneexpression
Authors: Endres, M Fan, GP Hirt, L Fujii, M Matsushita, K Liu, X Jaenisch, R Moskowitz, MA
Citation: M. Endres et al., Ischemic brain damage in mice after selectively modifying BDNF or NT4 geneexpression, J CEREBR B, 20(1), 2000, pp. 139-144
DNA methyltransferase contributes to delayed ischemic brain injury
Authors: Endres, M Meisel, A Biniszkiewicz, D Namura, S Prass, K Ruscher, K Lipski, A Jaenisch, R Moskowitz, MA Dirnagl, U
Citation: M. Endres et al., DNA methyltransferase contributes to delayed ischemic brain injury, J NEUROSC, 20(9), 2000, pp. 3175-3181
Ferromagnetic-semiconductor-singlet-(or triplet) superconductor-ferromagnetic-semiconductor systems as possible logic circuits and switches
Authors: Kulic, ML Endres, M
Citation: Ml. Kulic et M. Endres, Ferromagnetic-semiconductor-singlet-(or triplet) superconductor-ferromagnetic-semiconductor systems as possible logic circuits and switches, PHYS REV B, 62(17), 2000, pp. 11846-11853
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
Authors: Laufs, U Gertz, K Huang, P Nickenig, G Bohm, M Dirnagl, U Endres, M
Citation: U. Laufs et al., Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice, STROKE, 31(10), 2000, pp. 2442-2448
Neuroprotection mediated by changes in the endothelial actin cytoskeleton
Authors: Laufs, U Endres, M Stagliano, N Amin-Hanjani, S Chui, DS Yang, SX Simoncini, T Yamada, M Rabkin, E Allen, PG Huang, PL Bohm, M Schoen, FJ Moskowitz, MA Liao, JK
Citation: U. Laufs et al., Neuroprotection mediated by changes in the endothelial actin cytoskeleton, J CLIN INV, 106(1), 2000, pp. 15-24
Mechanical quality of tissue engineered cartilage: Results after 6 and 12 weeks in vivo
Authors: Duda, GN Haisch, A Endres, M Gebert, C Schroeder, D Hoffmann, JE Sittinger, M
Citation: Gn. Duda et al., Mechanical quality of tissue engineered cartilage: Results after 6 and 12 weeks in vivo, J BIOMED MR, 53(6), 2000, pp. 673-677
Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription
Authors: Laufs, U Endres, M Custodis, F Gertz, K Nickenig, G Liao, JK Bohm, M
Citation: U. Laufs et al., Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription, CIRCULATION, 102(25), 2000, pp. 3104-3110
Regulation of endothelial NO production by Rho GTPase
Authors: Laufs, U Endres, M Liao, JK
Citation: U. Laufs et al., Regulation of endothelial NO production by Rho GTPase, MED KLIN, 94(4), 1999, pp. 211-218
Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade
Authors: Fink, KB Andrews, LJ Butler, WE Ona, VO Li, M Bogdanov, M Endres, M Khan, SQ Namura, S Stieg, PE Beal, MF Moskowitz, MA Yuan, J Friedlander, RM
Citation: Kb. Fink et al., Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade, NEUROSCIENC, 94(4), 1999, pp. 1213-1218
Tim9, a new component of the TIM22 center dot 54 translocase in mitochondria
Authors: Adam, A Endres, M Sirrenberg, C Lottspeich, F Neupert, W Brunner, M
Citation: A. Adam et al., Tim9, a new component of the TIM22 center dot 54 translocase in mitochondria, EMBO J, 18(2), 1999, pp. 313-319
Transport of the ADP ATP carrier of mitochondria from the TOM complex to the TIM22.54 complex
Authors: Endres, M Neupert, W Brunner, M
Citation: M. Endres et al., Transport of the ADP ATP carrier of mitochondria from the TOM complex to the TIM22.54 complex, EMBO J, 18(12), 1999, pp. 3214-3221
Visual dysfunction in patients receiving vigabatrin - Clinical and electrophysiologic findings
Authors: Miller, NR Johnson, MA Paul, SR Girkin, CA Perry, JD Endres, M Krauss, GL
Citation: Nr. Miller et al., Visual dysfunction in patients receiving vigabatrin - Clinical and electrophysiologic findings, NEUROLOGY, 53(9), 1999, pp. 2082-2087
Neuroprotective effects of gelsolin during murine stroke
Authors: Endres, M Fink, K Zhu, JM Stagliano, NE Bondada, V Geddes, JW Azuma, T Mattson, MP Kwiatkowski, DJ Moskowitz, MA
Citation: M. Endres et al., Neuroprotective effects of gelsolin during murine stroke, J CLIN INV, 103(3), 1999, pp. 347-354
Risultati: 1-20 |